Main abnormalities | Consequence |
---|---|
Increased levels of TNF-α, IL-6, and CRP and decreased levels of IL-1β and IL-8 [22] | rMDD |
Increased activity of corticotropin-releasing hormone and hyperactivity of the HPA axis [15] | MDD progression and predicted recurrence |
Subsequent development of depressive symptoms (e.g., tiredness, lack of energy, sleep problems, and changes in appetite) | |
Increased inflammatory activity [25] | TRD |
Tryptophan metabolism and the levels of gamma-aminobutyric acid, dopamine, and serotonin | |
Cognitive behavior therapy [28] | Inflammatory processes Relief of MDD symptoms Anhedonia and motor retardation |